A detailed history of Gts Securities LLC transactions in Genmab A/S stock. As of the latest transaction made, Gts Securities LLC holds 74,356 shares of GMAB stock, worth $1.53 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
74,356
Holding current value
$1.53 Million
% of portfolio
0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025

BUY
$20.02 - $24.15 $1.49 Million - $1.8 Million
74,356 New
74,356 $1.55 Billion
Q4 2023

Feb 14, 2024

BUY
$27.94 - $35.44 $260,875 - $330,903
9,337 New
9,337 $297,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.5B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.